Assays
Ended Purchase Order Awarded Last action
- Contract number
- 75N91019P00687
- Awardee
-
Invivoscribe, Inc. UEI R1EVMK8MEZS9
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $12,038
Award facts
- Contract value 100% obligated
- $12,038.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$7 | |
| Original award | $12,045 |
About this award
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $12,038.04 firm fixed price purchase order to Invivoscribe, Inc. for assays. The place of performance is in San Diego, California and the completion date is January 31, 2024. As no set aside was used, the award was unrestricted. Invivoscribe will deliver the requested assays to support the National Cancer Institute's research efforts.
Quick answers
Who was awarded contract 75N91019P00687?
75N91019P00687 was awarded to Invivoscribe, Inc. by National Cancer Institute (National Institutes of Health) on August 26, 2019.
How much is contract 75N91019P00687 worth?
The government has obligated $12,038 on 75N91019P00687.
Was contract 75N91019P00687 competed?
The extent of competition for 75N91019P00687 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award